This work is licensed under a Creative Commons Attribution 4.0 International License.
| DRACP ID | Peptide Name | Sequence | Sequence Length | Origin |
|---|---|---|---|---|
| DRACP02486 | [Lys4, Lys5, Lys15, Lys16] XT-7 | GLLKKLLKIAAKVGKKLL | 18 | Synthetic (Derived from XT-7) |
| DRACP02487 | P6 (SEQ ID NO:1 for Patent US 20030186868 A1) | RRPKGRGKRRREKQRP | 16 | Synthetic |
| DRACP02488 | P6V8 (SEQ ID NO:4 for Patent US 20030186868 A1) | RRPKGRGKRRREKQRPCDKPRR | 22 | Synthetic |
| DRACP02489 | P6V8CS (SEQ ID NO:5 for Patent US 20030186868 A1) | RRPKGRGKRRREKQRPSDKPRR | 22 | Synthetic |
| DRACP02490 | P6P7 (SEQ ID NO:7 for Patent US 20030186868 A1) | RRPKGRGKRRREKQRPDAVPRR | 22 | Synthetic |
| DRACP02491 | P6V8-3NCS1-7CC (SEQ ID NO:12 for Patent US 20030186868 A1) | CKGRGKRCREKQRPSDKPRR | 20 | Synthetic |
| DRACP02492 | P6V8-3N (SEQ ID NO:13 for Patent US 20030186868 A1) | KGRGKRRREKQRPCDKPRR | 19 | Synthetic |
| DRACP02493 | P6V8-8N (SEQ ID NO:14 for Patent US 20030186868 A1) | RRREKQRPCDKPRR | 14 | Synthetic |
| DRACP02494 | P6V8-3NCS-1C (SEQ ID NO:17 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDKPR | 18 | Synthetic |
| DRACP02495 | P6V8-3NCS-2C (SEQ ID NO:18 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDKP | 17 | Synthetic |
| DRACP02496 | P6V8-3NCS (SEQ ID NO:20 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02497 | AS-2 (SEQ ID NO:22 for Patent US 20030186868 A1) | RRPKGRAAARREKQRPSDKPRR | 22 | Synthetic |
| DRACP02498 | AS-3 (SEQ ID NO:23 for Patent US 20030186868 A1) | RRPKGRGKRAAAKQRPSDKPRR | 22 | Synthetic |
| DRACP02499 | P6V8-3NCSA1 (SEQ ID NO:24 for Patent US 20030186868 A1) | AGRGKRRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02500 | P6V8-3NCSA5 (SEQ ID NO:25 for Patent US 20030186868 A1) | KGRGARRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02501 | P6V8-3NCSA3 (SEQ ID NO:27 for Patent US 20030186868 A1) | KGAGKRRREKQRPSDKPRR | 19 | Synthetic |
| DRACP02502 | P6V8-3NCSA6 (SEQ ID NO:28 for Patent US 20030186868 A1) | KGRGKARREKQRPSDKPRR | 19 | Synthetic |
| DRACP02503 | P6V8-3NRGCS (SEQ ID NO:31 for Patent US 20030186868 A1) | KGRGKRRREKQGPSDKPRR | 19 | Synthetic |
| DRACP02504 | P6V8-3NCSA16,18,19 (SEQ ID NO:32 for Patent US 20030186868 A1) | KGRGKRRREKQRPSDAPAA | 19 | Synthetic |
| DRACP02505 | P6V8-3NCSA7,8,10 (SEQ ID NO:33 for Patent US 20030186868 A1) | KGRGKRAAEAQRPSDKPRR | 19 | Synthetic |
| DRACP02506 | P6V8-3NCSA7,8,12 (SEQ ID NO:34 for Patent US 20030186868 A1) | KGRGKRAAEKQAPSDKPRR | 19 | Synthetic |
| DRACP02507 | P6V8-3NCSA1,5,7,8,10 (SEQ ID NO:35 for Patent US 20030186868 A1) | AGRGARAAEAQRPSDKPRR | 19 | Synthetic |
| DRACP02508 | AS-5 (SEQ ID NO:39 for Patent US 20030186868 A1) | RRPKGRGKRRREKQRPSDAAAR | 22 | Synthetic |
| DRACP02509 | Chemokinostatin-1 | NGRKACLNPASPIVKKIIEKMLNS | 24 | Homo sapiens (CXCL1/Gro-α) |
| DRACP02510 | Chemokinostatin-3 | NGKKACLNPASPMVQKIIEKIL | 22 | Homo sapiens (CXCL3/Gro-γ) |
| DRACP02511 | Chemokinostatin-5 | NGKEICLDPEAPFLKKVIQKILD | 23 | Homo sapiens (CXCL5/ENA-78) |
| DRACP02512 | Chemokinostatin-6 | NGKQVCLDPEAPFLKKVIQKILDS | 24 | Homo sapiens (CXCL6/GCP-2) |
| DRACP02513 | Chemokinostatin-7 | DGRKICLDPDAPRIKKIVQKKL | 22 | Homo sapiens (CXCL7/PBP) |
| DRACP02514 | Chemokinostatin-8 | DGRELCLDPKENWVQRVVEKFLK | 23 | Homo sapiens (CXCL8/IL-8) |
| DRACP02515 | N17 | KILRGVSKKIMRTFLRR | 17 | Synthetic |
This work is licensed under a Creative Commons Attribution 4.0 International License.